Prevent Cervical Cancer The Silent Killer
Cervical cancer remains one of the most preventable forms of cancer, yet it continues to claim lives at an alarming rate.
1 Indian woman dies every 7 minutes due to cervical cancer, making it a critical public health emergency that demands immediate action.
Unlike many other cancers, cervical cancer develops slowly over years, giving us a crucial window of opportunity for prevention and early detection. When caught early, cervical cancer has a survival rate of over 90%, but when detected in later stages, survival drops dramatically to less than 25%.
Why Prevention Matters More Than Ever
The Current Crisis
High mortality rates:
Approximately 60% of cervical cancer deaths occur due to late-stage diagnosis and limited treatment access
Economic devastation:
Late-stage cervical cancer treatment costs can exceed $12,000 compared to $1,000 for Stage I treatment
Limited screening:
Only 29.8% of Indian women undergo cervical cancer screening once in their lifetime
Catastrophic family impact:
Treatment expenses often exceed annual family income, pushing over 70% of patients into financial distress
The Prevention Opportunity
Studies provide robust evidence that regular screening reduces cancer burden by 80% or more. A nested case-control study showed that regular screening:
Reduces Stage 1A cancer by
67%
Reduces Stage 3 or worse cancer by
95%
Leads to an
80%
or more mortality reduction
Three Pillars of Cervical Cancer Prevention
Education and Awareness
Knowledge is your first line of defense
Understand risk factors:
HPV infection, multiple sexual partners, smoking, and immunocompromised conditions
Recognize early warning signs:
Abnormal vaginal bleeding, pelvic pain, and unusual discharge
Combat stigma:
Cervical cancer screening is a routine health measure, not a source of shame
HPV Vaccination
Prevent the cause before it starts
Ages 9-14:
2 doses, 6-12 months apart
Ages 15-26:
3 doses for those starting the series in this age range
Protection:
Vaccines protect against high-risk HPV types that cause 70% of cervical cancers
Regular Screening
Early detection saves lives and money
Early-stage cervical cancer treatment is 10 times cheaper than late-stage care, making screening not just a health imperative but an economic necessity.
Advanced Screening Technology: DNA Ploidy Testing Revolutionary Accuracy
Traditional screening methods often fall short:
LBC PAP tests: Miss approximately 35% of high-grade lesions
HPV DNA tests: 84.6% specificity with frequent false positives
DNA Ploidy testing offers breakthrough accuracy:
98% sensitivity and
100% specificity
Detects cancer up to 2 years before conventional methods
Objective, quantitative results eliminate observer bias
Benefits of DNA Ploidy Testing
Enhanced early detection:
Detects over 90% of cervical cancer cases at pre-cancer or Stage 1
Cost-effective interventions:
Early-stage treatments are 10 times cheaper
Objective treatment planning:
Quantitative data complements other diagnostic methods
Effective monitoring: Non-invasive follow-up reduces retreatment costs
High patient compliance: Brush-based testing is widely accepted
How DNA Ploidy Testing Works
Simple brush collection: Non-invasive, painless sample collection
Advanced staining: Feulgen staining highlights DNA content
Whole slide imaging: High-resolution scanning captures every cell
AI-powered analysis: Automated measurement of DNA content
Quantitative results: Abnormal (aneuploid) cells are flagged for review
Screening Recommendations
Who Should Be Screened
Women aged 21-65: Regular screening regardless of vaccination status
High-risk individuals: Those with HPV infection, multiple partners, or immunocompromised conditions
Post-treatment patients: Regular monitoring for recurrence
Screening Schedule
Ages 21-29: Every 3 years with cytology
Ages 30-65: Every 5 years with HPV testing plus cytology, or every 3 years with cytology alone
Post-treatment: As recommended by healthcare provider
Cervical cancer prevention is not just possible—it’s essential. With advanced screening technologies like DNA Ploidy testing, over 90% of cases can be detected at pre-cancer or Stage 1, when treatment is most effective and affordable.